New patient-friendly option to be made available for Tev-Tropin JERUSALEM & EWING, N.J.–(HSMN NewsFeed)–Teva Clinical Industries Ltd. (Nasdaq: TEVA ) and its senior partner, Antares Pharma, Inc. (NYSE Amex: AIS) today announced the approval of a Flexible…
Biopharmaceuticals, Drug Delivery, FDA
Teva Medical, Antares Pharma, Tev-Tropin

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Teva and Antares Announce FDA Approval of Needle-Free Injector Product for Administration of Tev-Tropin(R) (Human Growth Hormone)”
Leave a Comment